Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2026-01-04 @ 5:52 PM
Study NCT ID:
NCT00623805
Status:
COMPLETED
Last Update Posted:
2014-08-08
First Post:
2008-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-03
Start Date Type:
None
Primary Completion Date:
2012-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-18
First Submit QC Date:
None
Study First Post Date:
2008-02-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-06-06
Results First Submit QC Date:
None
Results First Post Date:
2014-08-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-07-16
Last Update Post Date:
2014-08-08
Last Update Post Date Type:
ESTIMATED